Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 2.3B
Gross Profit 1.0B 43.34%
Operating Income 209.6M 8.92%
Net Income 38.2M 1.63%
EPS (Diluted) $1.31

Balance Sheet Metrics

Total Assets 2.1B
Total Liabilities 958.7M
Shareholders Equity 1.2B
Debt to Equity 0.81

Cash Flow Metrics

Operating Cash Flow 144.5M
Free Cash Flow 214.3M

Revenue & Profitability Trend

Amedisys Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue2.3B2.2B2.2B2.2B2.1B
Cost of Goods Sold1.3B1.2B1.3B1.2B1.2B
Gross Profit1.0B990.9M962.8M980.8M886.2M
Operating Expenses790.1M780.1M754.1M697.9M633.9M
Operating Income209.6M193.1M183.8M251.9M223.4M
Pre-tax Income86.2M39.6M160.2M280.2M210.8M
Income Tax48.1M50.6M42.5M70.1M25.6M
Net Income38.2M-10.9M117.7M210.2M185.2M
EPS (Diluted)$1.31-$0.30$3.63$6.34$5.52

Income Statement Trend

Amedisys Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets632.1M496.9M389.0M356.7M362.0M
Non-Current Assets1.5B1.6B1.6B1.5B1.2B
Total Assets2.1B2.1B2.0B1.9B1.6B
Liabilities
Current Liabilities514.4M473.7M355.5M374.3M456.3M
Non-Current Liabilities444.4M466.7M514.1M506.4M300.1M
Total Liabilities958.7M940.4M869.7M880.6M756.5M
Equity
Total Shareholders Equity1.2B1.1B1.1B976.3M810.7M

Balance Sheet Composition

Amedisys Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income38.2M-10.9M117.7M210.2M185.2M
Operating Cash Flow144.5M116.7M163.9M246.6M264.8M
Investing Activities
Capital Expenditures-6.6M-5.5M-6.1M-6.2M-5.3M
Investing Cash Flow-7.5M42.2M-93.4M-281.2M-287.1M
Financing Activities
Dividends Paid-----
Financing Cash Flow-49.2M-90.2M-36.6M-1.9M-43.9M
Free Cash Flow214.3M124.5M126.1M182.2M283.6M

Cash Flow Trend

Amedisys Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 35.87
Forward P/E 19.02
Price to Book 2.66
Price to Sales 1.35
PEG Ratio 19.02

Profitability Ratios

Profit Margin 3.79%
Operating Margin 10.11%
Return on Equity 7.15%
Return on Assets 6.36%

Financial Health

Current Ratio 1.29
Debt to Equity 36.30
Beta 0.94

Per Share Data

EPS (TTM) $2.71
Book Value per Share $36.55
Revenue per Share $72.42

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
amed3.2B35.872.667.15%3.79%36.30
HCA Healthcare 91.0B16.80-209.921,605.77%8.07%-106.02
Tenet Healthcare 15.7B10.853.7628.82%7.09%152.20
Ensign Group 8.5B27.834.3717.64%7.00%104.09
Chemed 6.8B22.675.7326.11%12.40%12.28
Option Care Health 5.1B24.783.7615.38%4.12%90.53

Financial data is updated regularly. All figures are in the company's reporting currency.